Author

Z. Ye

Institution: Gilead Sciences (United States)

Observed institution: Gilead Sciences (United States)

OpenAlex ID: A5022913536

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

2016 · W. J. Sandborn, B. R. Bhandari, et al. · Alimentary Pharmacology & Therapeutics · 62

Works count: 1

Citation count: 62

H-index: 1

I10-index: 1